2018 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | 600-700 |
Total Number of Projects: | > 1000 |
2016 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2015 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 3
Sole participant: 1
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2022 | 0 | 2.530.901 | 274.370 | 1 | ||
2018 | 2.336.268 | 0 | 2.336.268 | 1 | ||
2016 | 0 | 3.920.630 | 255.374 | 1 | ||
2015 | 0 | 5.999.990 | 662.500 | 1 |
Total number of partners: 33
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 33
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2022-09-01 | NAD+ International Scientist-training | NADIS | participant | 2.530.901 | 18 |
2018-10-01 | Late Clinical Development of KH176: an innovative orphan drug to reach mitochondrial disease patients & market | KHON2bTREAT | coordinator | 2.336.268 | 1 |
2016-10-01 | Regulation of mitochondrial expression | REMIX | participant | 3.920.630 | 10 |
2015-12-01 | Systems Medicine of Mitochondrial Parkinson’s Disease | SysMedPD | participant | 5.999.990 | 8 |